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Dear Editor. Almost one quarter of stroke survivors experience foot drop leading to walking 
disturbance, fatigue and risk of falling.1 This limitation affects functional mobility, autonomy 
and quality of life.2 Several therapeutic approaches that reinforce dorsiflexors include physical 
therapy, electromyostimulation, functional electrical stimulation (FES), or maintenance of the 
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ankle in an appropriate position during gait (e.g., orthosis). In addition, anti-spastic medication 
can be used to facilitate dorsiflexion and improve gait.  
An implanted FES device has been developed to facilitate the use of FES. This technique has 
been shown to improve gait and is well tolerated by users.3,4 An open-label longitudinal study 
evaluated the effect of an implanted FES stimulator (ActiGait®, Ottobock, Germany) on gait 
after 1 year of use in individuals with chronic stroke.5 The authors found a significant 
improvement in dorsiflexion, similar to what was observed with surface FES. Two other studies 
by Berenpas and collaborators compared the effects of implanted FES to conventional ankle-
foot orthosis in individuals with chronic stroke, showing superior improvement in knee 
stability, ankle plantarflexion power, and propulsion with FES versus ankle-foot orthosis 6 as 
well as better adaptation of the gait pattern to environmental disturbances.7 The same team also 
demonstrated that long-term use of implanted FES could increase muscle thickness and 
normalize motor-evoked potential on the paretic side.8  
In the present study, we assessed the potential effects of implanted FES on both behavior and 
cortical plasticity in individuals after stroke by using 18F-fluorodeoxyglucose positron 
emission tomography (FDG-PET) and structural and functional MRI (fMRI).  
We included individuals who presented foot drop due to stroke > 9 months after stroke, 
hemiparesis, no functional improvement (i.e., no significant changes on the 6-min walk test 
[6MWT] and 10-m walk test [10MWT] performed during daily clinical follow-up) within the 
last 6 months, stable medical condition, positive results (i.e., improvement in gait) with an 
external FES, positive MRI results of the knee after FES implantation (i.e., distance between 
the stimulator and skin < 40 mm) and written informed consent. Exclusion criteria included 
peripheral nerve lesions of the affected leg, lesion of the skin or a sensitive skin, diabetes, 
previous neurological diseases and MRI/FDG-PET contraindication. The protocol was the same 
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as described in a previous case report.9 Patients underwent surgery to place the FES stimulator 
(ActiGait®) over the motor branch of the common peroneal nerve. Three weeks after the surgery 
but before activation of the stimulator, patients underwent MRI and FDG-PET (i.e., baseline). 
Then, the FES was activated and patients came back for a second examination the following 
year (i.e., 1-year MRI and FDG-PET). The FES was programmed to send a current of 1.1 mA 
for each patient. Pulse rate and duration were defined for each patient during activation of the 
implant. The FES was optimized during the first month of implant use to fit the patients’ gait 
pattern. Behavioral evaluations performed before and after activation of the FES tested walking 
and endurance, speed, and dynamic balance with the 6MWT, 10MWT and Four Square Step 
Test (FSST), respectively. Clinical assessments were performed at 1 year while the stimulator 
was ON. The study was approved by the National Research Ethics Committee of Luxembourg. 
All individuals with stroke and healthy controls gave their written consent and the study 
followed the STROBE statement.   
Neuroimaging data of patients with a lesion over the right hemisphere were flipped to have all 
brain lesions on the same side (i.e., left). FDG-PET data were preprocessed with spatial 
normalization, smoothing (Gaussian kernel 12 mm full width at a half maximum) and 
proportional scaling, implemented in Statistical Parametric Mapping toolbox (SPM8). The 
design matrix separately modeled PET scans for individuals with stroke (PET 1 and PET 2) and 
34 age-matched healthy controls, as published elsewhere.11 We used a T1-based voxel-based 
morphometry analysis of brain structure (VBM8) along with SPM8 to search for potential 
morphological differences in grey matter (GM) density, as described.12 We used DARTEL-
based spatial normalization and smoothed the data with Gaussian isotropic kernel (8 mm of 
full-width-at-half-maximum). In total, 300 T2*-weighted resting-state fMRI volumes were 
acquired by using a 1.5T Siemens TIM Trio MRI scanner. Pre- and post-processing were as 
described 13. For measuring fMRI resting-state functional connectivity, a seed-based approach 
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was used with the connectivity toolbox CONN. The seed-correlation analysis extracts fMRI 
BOLD time series from a region of interest and determines the temporal correlation between 
this signal and the time series from all other brain voxels. We compared the functional 
connectivity between 2 regions showing peak results in the FDG-PET analysis (i.e., ispsilateral 
and contralateral premotor cortex – BA6) and the time series from all other brain voxels in the 
brain before and 1 year after the stimulator activation in all stroke individuals. For VBM and 
fMRI analyses, data for stroke individuals were compared to an age-matched group of 8 healthy 
volunteers. All results were considered statistically significant at p<0.05 (false discovery rate 
[FDR]).    
Thirteen patients successfully completed the study (5 females, mean [SD] age 46 [12] years, 4 
right- and 9 left-sided, 6 hemorrhagic and 7 ischemic stroke; mean time since stroke 29 [16] 
months; see Table). All patients presented functional improvement for at least one assessed 
function (i.e., 6MWT, 10MWT, and FSST).  
For FDG-PET, statistical analyses demonstrated hypometabolism in the lesioned hemisphere at 
baseline, mostly in motor and frontal regions (Fig. A, red and purple). At 1-year follow-up, 
brain metabolism was increased in the primary and secondary sensorimotor cortex, premotor 
area, cerebellum and associative areas such as frontal, parietal and occipital regions (Fig. A, 
red). At baseline, VBM analysis showed extensive regional GM atrophy in the damaged 
hemisphere, involving the lateral fronto-parietal and temporal hemisphere, caudatum, thalamus 
and cerebellum (Fig. B, red and purple). At 1-year follow-up, GM was increased in the 
ipsilateral (to the brain lesion) sensorimotor regions and inferior frontal cortex (Fig. 1B, red) 
and decreased in the ipsilateral (to the brain lesion) orbitofrontal cortex, cingulate cortex and 
occipital cortex (Fig. 1B, blue). For fMRI analysis, one participant was excluded because of 
excessive movement artifacts. In comparing baseline to 1-year follow-up, functional 
connectivity significantly increased between the seed in the motor cortex of the lesioned 
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hemisphere (x = 24, y = 4, z = 72) and the insula and operculum in the same damaged 
hemisphere (x = -42, y = 8, z = 2; cluster p-FDR=0.04) (Fig. C). We found no significant 
difference with the contralateral motor seed.  
Our group results support that after using ActiGait® for 12 months, metabolic, structural, and 
functional connectivity change in the lesioned hemisphere in individuals with chronic stroke 
and foot drop. These findings suggest that structural and functional brain reorganization 
continue to occur with prolonged use of implanted FES in individuals with chronic stroke. 
However, we also found reduced GM at 1 year in the damaged hemisphere (orbitofrontal, 
cingulate and occipital cortices), which could reflect global brain atrophy and/or be related to 
symptom worsening that was not collected in the present study.  
We show that peripheral stimulation can modulate and improve connectivity even years after 
the stroke (the longest time since injury was 5.9 years). This improvement within the damaged 
hemisphere may be clinically more promising as compared with increased activity in the 
controlesional brain area given that individuals with stroke who recover some brain activity in 
the damaged hemisphere have better functional outcomes than those with an increase in brain 
activity in the undamaged hemisphere only.14 We observed increased metabolism at 1-year 
follow-up in a large network involved in movement planning and execution, namely the primary 
and secondary sensorimotor cortex (postcentral gyrus), premotor area (precentral gyrus), 
cerebellum and associated areas such as frontal (frontopolar prefrontal cortex), parietal 
(supramarginal gyrus) and occipital (superior occipital gyrus) regions. Furthermore, the motor 
cortex showed increased functional connectivity with the insula, a brain region thought to be 
involved, among others, in motor control.15 The improvement in function within this network 
and not just in the primary motor cortex could reflect the recovery of the ability to perform 
more complex movement and not just simple or automatic motor tasks. In this context, our 
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findings suggest an improvement in foot drop but also a more widespread functional recovery 
of gait function.  
One main limitation of this study is the lack of a control group of stroke individuals and foot 
drop without implanted FES. So far, no controlled randomized clinical trial of individuals with 
chronic stroke has evaluated the effect of implanted FES on foot drop, so discriminating natural 
recovery from an intervention effect in both the present study or previous ones focusing on 
clinical outcomes is difficult.16 Another potential limitation is our limited sample size. Because 
of the small sample and its heterogeneity, any generalizability of our results is cautioned.  
In conclusion, the present study shows that motor recovery following implanted FES in 
individuals with chronic stroke parallel functional and structural brain changes in the affected 
brain hemisphere. Large randomized controlled clinical trials, including a placebo group and 
combining functional assessments with neuroimaging techniques, are warranted to disentangle 
natural from treatment-related improvement and confirm the positive effects of this peroneal 
nerve stimulator in stroke rehabilitation. Neuroimaging and neurophysiological recordings 
could also help identify biomarkers of functional improvement and better target a sub-group of 
individuals who could benefit from this therapeutic approach. Peroneal nerve stimulation 
provides a unique, painless and promising way to help individuals with stroke enhance their 
gait function, although the related intervention is invasive and implies some risks.  
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Figure legend 
Figure. A) 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) results. 
Hypometabolic brain areas at baseline (in red) and at 1-year follow-up (in blue, covered by the 
hypometabolism at baseline), compared to controls. In purple, the overlap between the 2 
comparisons. Hence, red color shows the areas of hypometabolism present at baseline but not 
at 1-year follow-up. No areas were more hypometabolic at 1-year follow-up. B) Voxel based 
morphometry (VBM) result. Brain areas of gray-matter (GM) atrophy at baseline (in red) and 
at 1-year follow-up (in blue), compared to controls. In purple, the overlap between the 2 
comparisons. Hence, red color shows the areas of GM atrophy present at baseline but not at 1-
year follow-up; blue color shows the areas of GM atrophy present at 1-year follow-up and not 
at baseline. C) Functional MRI (fMRI) connectivity result. The motor cortex of the affected 
hemisphere is more connected to a region overlapping the insula and operculum after 1 year of 
functional electrical stimulation (FES; in red). Statistical maps are thresholded at p<0.05 false 
discovery rate corrected at the whole brain level (A, B, C) and are rendered on the axial, midline 
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